vs
Pediatrix Medical Group, Inc.（MD）とSimpson Manufacturing Co., Inc.（SSD）の財務データ比較。上の社名をクリックして会社を切り替えられます
Simpson Manufacturing Co., Inc.の直近四半期売上が大きい（$539.3M vs $493.8M、Pediatrix Medical Group, Inc.の約1.1倍）。Simpson Manufacturing Co., Inc.の純利益率が高く（10.4% vs 6.8%、差は3.6%）。Simpson Manufacturing Co., Inc.の前年同期比売上増加率が高い（4.2% vs -1.7%）。過去8四半期でSimpson Manufacturing Co., Inc.の売上複合成長率が高い（0.8% vs -0.1%）
Pediatrix Medical Group, Inc.は米国を代表する専門医療サービスプロバイダーで、母胎医療、新生児科、小児心臓病学などの小児亜専門を中心に事業を展開し、米国全土の医療機関と提携して女性、新生児、子どもに根拠に基づく質の高い医療を提供しています。
シンプソン・マニュファクチャリングは米国屈指の建築資材メーカーで、新築工事や改修工事向けの構造用接合金物、ファスナー、アンカーなどの製品を製造・供給しており、業界で高い技術力と市場シェアを誇っています。
MD vs SSD — 直接比較
損益計算書 — Q4 FY2025 vs Q4 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $493.8M | $539.3M |
| 純利益 | $33.7M | $56.2M |
| 粗利率 | — | 43.4% |
| 営業利益率 | 9.9% | 13.9% |
| 純利益率 | 6.8% | 10.4% |
| 売上前年比 | -1.7% | 4.2% |
| 純利益前年比 | 10.5% | 1.4% |
| EPS（希薄化後） | $0.40 | $1.34 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $493.8M | $539.3M | ||
| Q3 25 | $492.9M | $623.5M | ||
| Q2 25 | $468.8M | $631.1M | ||
| Q1 25 | $458.4M | $538.9M | ||
| Q4 24 | $502.4M | $517.4M | ||
| Q3 24 | $511.2M | $587.2M | ||
| Q2 24 | $504.3M | $597.0M | ||
| Q1 24 | $495.1M | $530.6M |
| Q4 25 | $33.7M | $56.2M | ||
| Q3 25 | $71.7M | $107.4M | ||
| Q2 25 | $39.3M | $103.5M | ||
| Q1 25 | $20.7M | $77.9M | ||
| Q4 24 | $30.5M | $55.4M | ||
| Q3 24 | $19.4M | $93.5M | ||
| Q2 24 | $-153.0M | $97.8M | ||
| Q1 24 | $4.0M | $75.4M |
| Q4 25 | — | 43.4% | ||
| Q3 25 | — | 46.4% | ||
| Q2 25 | — | 46.7% | ||
| Q1 25 | — | 46.8% | ||
| Q4 24 | — | 44.0% | ||
| Q3 24 | — | 46.8% | ||
| Q2 24 | — | 46.7% | ||
| Q1 24 | — | 46.1% |
| Q4 25 | 9.9% | 13.9% | ||
| Q3 25 | 13.8% | 22.6% | ||
| Q2 25 | 12.8% | 22.2% | ||
| Q1 25 | 7.0% | 19.0% | ||
| Q4 24 | 7.8% | 14.8% | ||
| Q3 24 | 6.6% | 21.3% | ||
| Q2 24 | -31.3% | 22.1% | ||
| Q1 24 | 3.2% | 18.1% |
| Q4 25 | 6.8% | 10.4% | ||
| Q3 25 | 14.5% | 17.2% | ||
| Q2 25 | 8.4% | 16.4% | ||
| Q1 25 | 4.5% | 14.5% | ||
| Q4 24 | 6.1% | 10.7% | ||
| Q3 24 | 3.8% | 15.9% | ||
| Q2 24 | -30.3% | 16.4% | ||
| Q1 24 | 0.8% | 14.2% |
| Q4 25 | $0.40 | $1.34 | ||
| Q3 25 | $0.84 | $2.58 | ||
| Q2 25 | $0.46 | $2.47 | ||
| Q1 25 | $0.24 | $1.85 | ||
| Q4 24 | $0.37 | $1.31 | ||
| Q3 24 | $0.23 | $2.21 | ||
| Q2 24 | $-1.84 | $2.31 | ||
| Q1 24 | $0.05 | $1.77 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $375.2M | $384.1M |
| 総負債低いほど良い | $570.5M | $300.0M |
| 株主資本純資産 | $865.9M | $2.0B |
| 総資産 | $2.2B | $3.1B |
| 負債/資本比率低いほどレバレッジが低い | 0.66× | 0.15× |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $375.2M | $384.1M | ||
| Q3 25 | $340.1M | $297.3M | ||
| Q2 25 | $224.7M | $190.4M | ||
| Q1 25 | $99.0M | $150.3M | ||
| Q4 24 | $229.9M | $239.4M | ||
| Q3 24 | $103.8M | $339.4M | ||
| Q2 24 | $19.4M | $354.9M | ||
| Q1 24 | $8.0M | $369.1M |
| Q4 25 | $570.5M | $300.0M | ||
| Q3 25 | $577.2M | $371.3M | ||
| Q2 25 | $583.9M | $376.9M | ||
| Q1 25 | $590.5M | $382.5M | ||
| Q4 24 | $597.1M | $388.1M | ||
| Q3 24 | — | $393.8M | ||
| Q2 24 | — | $399.4M | ||
| Q1 24 | — | $405.0M |
| Q4 25 | $865.9M | $2.0B | ||
| Q3 25 | $890.7M | $2.0B | ||
| Q2 25 | $833.8M | $1.9B | ||
| Q1 25 | $789.2M | $1.9B | ||
| Q4 24 | $764.9M | $1.8B | ||
| Q3 24 | $732.5M | $1.9B | ||
| Q2 24 | $706.5M | $1.8B | ||
| Q1 24 | $856.2M | $1.7B |
| Q4 25 | $2.2B | $3.1B | ||
| Q3 25 | $2.2B | $3.0B | ||
| Q2 25 | $2.1B | $3.0B | ||
| Q1 25 | $2.0B | $2.8B | ||
| Q4 24 | $2.2B | $2.7B | ||
| Q3 24 | $2.1B | $2.9B | ||
| Q2 24 | $2.0B | $2.8B | ||
| Q1 24 | $2.2B | $2.7B |
| Q4 25 | 0.66× | 0.15× | ||
| Q3 25 | 0.65× | 0.19× | ||
| Q2 25 | 0.70× | 0.20× | ||
| Q1 25 | 0.75× | 0.21× | ||
| Q4 24 | 0.78× | 0.21× | ||
| Q3 24 | — | 0.21× | ||
| Q2 24 | — | 0.23× | ||
| Q1 24 | — | 0.23× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $114.1M | $155.7M |
| フリーキャッシュフロー営業CF - 設備投資 | — | $119.0M |
| FCFマージンFCF / 売上 | — | 22.1% |
| 設備投資強度設備投資 / 売上 | — | 6.8% |
| キャッシュ転換率営業CF / 純利益 | 3.39× | 2.77× |
| 直近12ヶ月FCF直近4四半期 | — | $297.6M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $114.1M | $155.7M | ||
| Q3 25 | $137.3M | $170.2M | ||
| Q2 25 | $137.2M | $125.2M | ||
| Q1 25 | $-117.5M | $7.6M | ||
| Q4 24 | $133.0M | $115.8M | ||
| Q3 24 | $91.8M | $103.3M | ||
| Q2 24 | $107.0M | $111.1M | ||
| Q1 24 | $-125.2M | $7.9M |
| Q4 25 | — | $119.0M | ||
| Q3 25 | — | $133.9M | ||
| Q2 25 | — | $87.3M | ||
| Q1 25 | — | $-42.6M | ||
| Q4 24 | — | $60.3M | ||
| Q3 24 | — | $58.1M | ||
| Q2 24 | — | $70.9M | ||
| Q1 24 | — | $-31.5M |
| Q4 25 | — | 22.1% | ||
| Q3 25 | — | 21.5% | ||
| Q2 25 | — | 13.8% | ||
| Q1 25 | — | -7.9% | ||
| Q4 24 | — | 11.7% | ||
| Q3 24 | — | 9.9% | ||
| Q2 24 | — | 11.9% | ||
| Q1 24 | — | -5.9% |
| Q4 25 | — | 6.8% | ||
| Q3 25 | — | 5.8% | ||
| Q2 25 | — | 6.0% | ||
| Q1 25 | — | 9.3% | ||
| Q4 24 | — | 10.7% | ||
| Q3 24 | — | 7.7% | ||
| Q2 24 | — | 6.7% | ||
| Q1 24 | — | 7.4% |
| Q4 25 | 3.39× | 2.77× | ||
| Q3 25 | 1.91× | 1.58× | ||
| Q2 25 | 3.49× | 1.21× | ||
| Q1 25 | -5.66× | 0.10× | ||
| Q4 24 | 4.36× | 2.09× | ||
| Q3 24 | 4.72× | 1.10× | ||
| Q2 24 | — | 1.14× | ||
| Q1 24 | -31.03× | 0.11× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
SSD
| Wood Construction | $352.0M | 65% |
| Other | $122.4M | 23% |
| Concrete Construction | $64.6M | 12% |
| Other Products | $318.0K | 0% |
